Drug intelligence / Profile preview

Weleda Arnica Zalf

Development stage
Unknown
Lead developer
Weleda
Administration
Topical
01

Overview

Weleda Arnica Zalf (also known as Weleda Arnica Ointment) is a topical homeopathic and anthroposophic medicinal product manufactured by Weleda. The active ingredient is a D1 dilution of *Arnica montana* (whole plant extract), formulated in a natural ointment base containing refined peanut oil, wool wax, wool wax alcohols, yellow wax, ethanol, and purified water. It is traditionally indicated for the treatment of blunt injuries, bruises, contusions, strains, and haematomas based on anthroposophical principles. In a clinical trial context, it has been investigated by Isala Klinieken in a randomized, double-blind, placebo-controlled trial for its efficacy in reducing postoperative edema and ecchymosis (bruising) in patients undergoing upper eyelid blepharoplasty. The product's mechanism of action involves the promotion of local blood circulation and the reduction of swelling to support tissue recovery.

Brand names
Weleda Arnica ZalfWeleda Arnica Ointment
Other names
Arnica D1 ointmentArnica montana ointment
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)NFKB1 (NF-κB1)IKK complexPTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on Weleda Arnica Zalf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weleda Arnica Zalf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call